Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Merck
Baxter
Harvard Business School
Medtronic
Johnson and Johnson

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Chartwell Molecular Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?

CHARTWELL MOLECULAR has nine approved drugs.

There is one tentative approval on CHARTWELL MOLECULAR drugs.

Summary for Chartwell Molecular
US Patents:0
Tradenames:9
Ingredients:9
NDAs:9

Drugs and US Patents for Chartwell Molecular

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecular RISPERIDONE risperidone TABLET;ORAL 077543-006 May 18, 2011 AB RX No No   Start Trial   Start Trial
Chartwell Molecular SERTRALINE HYDROCHLORIDE sertraline hydrochloride TABLET;ORAL 077162-002 Feb 6, 2007 DISCN No No   Start Trial   Start Trial
Chartwell Molecular CALCIUM ACETATE calcium acetate TABLET;ORAL 202420-001 Feb 5, 2013 AB RX No No   Start Trial   Start Trial
Chartwell Molecular RISPERIDONE risperidone TABLET;ORAL 077543-005 May 18, 2011 AB RX No No   Start Trial   Start Trial
Chartwell Molecular IRBESARTAN irbesartan TABLET;ORAL 077205-001 Nov 14, 2012 AB RX No No   Start Trial   Start Trial
Chartwell Molecular RAMIPRIL ramipril CAPSULE;ORAL 078745-003 Jun 18, 2008 AB RX No No   Start Trial   Start Trial
Chartwell Molecular RISPERIDONE risperidone TABLET;ORAL 077543-003 May 18, 2011 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Baxter
Merck
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.